74
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Ddb1-Cullin4-Associated-Factor 1 in Macrophages Restricts the Staphylococcus aureus-Induced Osteomyelitis

, , , , , , , , & show all
Pages 1667-1676 | Published online: 28 Apr 2021

References

  • Lew DP, Waldvogel FA. Osteomyelitis. The Lancet. 2004;364(9431):369–379. doi:10.1016/S0140-6736(04)16727-5
  • Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336(14):999–1007.
  • Kremers HM, Nwojo ME, Ransom JE, Wood-Wentz CM, Melton III LJ, Huddleston III PM. Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Joint Surg Am. 2015;97(10):837.
  • Brady R, Leid J, Costerton J, Shirtliff M. Osteomyelitis: clinical overview and mechanisms of infection persistence. Clin Microbiol Newsletter. 2006;28(9):65–72.
  • Fang RC, Galiano RD Adjunctive therapies in the treatment of osteomyelitis. Paper presented at: Seminars in plastic surgery. 2009.
  • Gogia JS, Meehan JP, Di Cesare PE, Jamali AA Local antibiotic therapy in osteomyelitis. Paper presented at: Seminars in plastic surgery. 2009.
  • Qiao Y, Liu X, Li B, et al. Treatment of MRSA-infected osteomyelitis using bacterial capturing, magnetically targeted composites with microwave-assisted bacterial killing. Nat Commun. 2020;11(1):1–13.
  • Wei S, Qiao Y, Wu Z, et al. Na+ inserted metal-organic framework for rapid therapy of bacteria-infected osteomyelitis through microwave strengthened Fenton reaction and thermal effects. Nano Today. 2021;37:101090.
  • Hofstee MI, Muthukrishnan G, Atkins GJ, et al. Current concepts of osteomyelitis: from pathological mechanisms to advanced research methods. Am J Pathol. 2020.
  • Masters EA, Trombetta RP, de Mesy Bentley KL, et al. Evolving concepts in bone infection: redefining “biofilm”,“acute vs. chronic osteomyelitis”,“the immune proteome” and “local antibiotic therapy”. Bone Res. 2019;7(1):1–18.
  • Olson ME, Horswill AR. Staphylococcus aureus osteomyelitis: bad to the bone. Cell Host Microbe. 2013;13(6):629–631.
  • Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7(2):178.
  • Jensen A, Espersen F, Skinhøj P, Rosdahl V, Frimodt-Møller N. Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990. J Infect. 1997;34(2):113–118.
  • Nelson DR, Buxton TB, Luu QN, Rissing JP. The promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis. J Thorac Cardiovasc Surg. 1990;99(6):977–980.
  • Mal S, Berendt A, Peacock S. Staphylococcus aureus bone and joint infection. J Infect. 2002;44(3):143–151.
  • Fu C, Shi R. Osteoclast biology in bone resorption: a review. STEMedicine. 2020;1(4):e57.
  • Peters K, Koberg K, Rosendahl T, Schmutzler W, Zwadlo-Klarwasser G. Alteration in the pattern of macrophage subtypes in chronic osteomyelitis compared with acute joint infection. Int Orthop. 1995;19(3):162–166.
  • Romani B, Cohen ÉA. Lentivirus Vpr and Vpx accessory proteins usurp the cullin4–DDB1 (DCAF1) E3 ubiquitin ligase. Curr Opin Virol. 2012;2(6):755–763.
  • Schabla NM, Mondal K, Swanson PC. DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor. J Mol Cell Biol. 2019;11(9):725–735.
  • McCall CM, de Marval PLM, Chastain PD, et al. Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development. Mol Cell Biol. 2008;28(18):5621–5633.
  • Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474(7353):658–661.
  • Francke A, Herold J, Weinert S, Strasser RH, Braun-Dullaeus RC. Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem. 2011;59(9):813–825.
  • Liu C, Ma H, Slitt AL, Seeram NP. Inhibitory effect of cannabidiol on the activation of NLRP3 inflammasome is associated with its modulation of the P2X7 receptor in human monocytes. J Nat Prod. 2020.
  • Shang W, Jiang Y, Boettcher M, et al. Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation. Proc Natl Acad Sci. 2018;115(17):E4051–E4060.
  • Liu C, Shen Y-J, Tu Q-B, et al. Pedunculoside, a novel triterpene saponin extracted from Ilex rotunda, ameliorates high-fat diet induced hyperlipidemia in rats. Biomed Pharmacother. 2018;101:608–616.
  • Yu C, Ji S-Y, Sha -Q-Q, Sun Q-Y, Fan H-Y. CRL4–DCAF1 ubiquitin E3 ligase directs protein phosphatase 2A degradation to control oocyte meiotic maturation. Nat Commun. 2015;6(1):1–11.
  • Guo Z, Kong Q, Liu C, et al. DCAF1 controls T-cell function via p53-dependent and-independent mechanisms. Nat Commun. 2016;7(1):1–13.
  • Le Rouzic E, Belaïdouni N, Estrabaud E, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle. 2007;6(2):182–188.
  • Wang Y, Lin Y, Cheng C, et al. NF-κB/TWIST1 mediates migration and phagocytosis of macrophages in the mice model of implant-associated Staphylococcus aureus osteomyelitis. Front Microbiol. 2020;11:1301.
  • Dapunt U, Maurer S, Giese T, Gaida MM, Hänsch GM. The macrophage inflammatory proteins MIP1 (CCL3) and MIP2 (CXCL2) in implant-associated osteomyelitis: linking inflammation to bone degradation. Mediators Inflamm. 2014;2014.
  • Mukherjee S, Karmakar S, Babu SP. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis. 2016;20(2):193–204.
  • Sun W, Liu C, Zhang Y, et al. Ilexgenin A, a novel pentacyclic triterpenoid extracted from Aquifoliaceae shows reduction of LPS-induced peritonitis in mice. Eur J Pharmacol. 2017;797:94–105.
  • Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11.
  • Huang G, Shi LZ, Chi H. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine. 2009;48(3):161–169.